Merck Says Vaccine Buyers Must Arbitrate Antitrust Suit
By Kevin Stawicki · September 18, 2020, 6:00 PM EDT
Merck Sharp & Dohme Corp. is doubling down on its bid to arbitrate claims in a proposed class action alleging it violated federal antitrust law by selling overpriced vaccines after the...
To view the full article, register now.